By contrast, in the California Teachers Study cohort, daily long-term use of aspirin was not associated with risk for ER+/PR+ breast cancer, but with a significantly increased risk for ER−/PR− breast cancer (Marshall et al, 2005). Here, PGR is linked to breast carcinoma.